CoChat

Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression

Open access
Saito, Erin R., Miller, Justin B., Harari, Oscar, Cruchaga, Carlos, Mihindukulasuriya, Kathie A., Kauwe, John S. K., Bikman, Benjamin T. · 2021 · Alzheimer's & Dementia
Cited by 59

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Introduction: Sporadic Alzheimer's disease (AD) is strongly correlated with impaired brain glucose metabolism, which may affect AD onset and progression. Ketolysis has been suggested as an alternative pathway to fuel the brain. Methods: RNA‐seq profiles of post mortem AD brains were used to determine whether dysfunctional AD brain metabolism can be determined by impairments in glycolytic and ketolytic gene expression. Data were obtained from the Knight Alzheimer's Disease Research Center (62 cases; 13 controls), Mount Sinai Brain Bank (110 cases; 44 controls), and the Mayo Clinic Brain Bank (80 cases; 76 controls), and were normalized to cell type: astrocytes, microglia, neurons, oligodendrocytes. Results: In oligodendrocytes, both glycolytic and ketolytic pathways were significantly impaired in AD brains. Ketolytic gene expression was not significantly altered in neurons, astrocytes, and microglia. Discussion: Oligodendrocytes may contribute to brain hypometabolism observed in AD. These results are suggestive of a potential link between hypometabolism and dysmyelination in disease physiology. Additionally, ketones may be therapeutic in AD due to their ability to fuel neurons despite impaired glycolytic metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12310

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 59

Metadata

Authors
Saito, E. R., Miller, J. B., Harari, O., Cruchaga, C., Mihindukulasuriya, K. A., Kauwe, J. S. K., & Bikman, B. T.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2021-03-02
Volume
17
Issue
9
Pages
1474-1486
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W3135898776
Cited by
59
References
18
FWCI
5.35
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression. https://app.cochat.ai/papers/10.1002/alz.12310
The paper
Saito, E. R., Miller, J. B., Harari, O., Cruchaga, C., Mihindukulasuriya, K. A., Kauwe, J. S. K., & Bikman, B. T. (2021). Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression. Alzheimer's & Dementia. https://doi.org/10.1002/alz.12310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.